BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19438904)

  • 1. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
    Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.
    Newman WG; Zhang Q; Liu X; Walker E; Ternan H; Owen J; Johnson B; Greer W; Mosher DP; Maksymowych WP; Bykerk VP; Keystone EC; Amos CI; Siminovitch KA
    Arthritis Rheum; 2006 Dec; 54(12):3820-7. PubMed ID: 17133579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
    Zeitlin AA; Heward JM; Brand OJ; Newby PR; Franklyn JA; Gough SC; Simmonds MJ
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):380-4. PubMed ID: 16918960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Graves' disease: the lost concept.
    Sibarani RP
    Acta Med Indones; 2009 Jan; 41(1):37-40. PubMed ID: 19258680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.
    Chistiakov DA; Savost'anov KV; Turakulov RI
    Mol Genet Metab; 2004 Nov; 83(3):264-70. PubMed ID: 15542398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of thyroid autoimmunity and the role of the TSHR.
    Brand OJ; Gough SC
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):135-43. PubMed ID: 20083159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
    Inoue N; Watanabe M; Yamada H; Takemura K; Hayashi F; Yamakawa N; Akahane M; Shimizuishi Y; Hidaka Y; Iwatani Y
    J Clin Immunol; 2012 Dec; 32(6):1243-52. PubMed ID: 22706687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies of genetic susceptibility to Graves' disease in a Russian population.
    Chistiakov DA; Savost'anov KV; Turakulov RI; Petunina N; Balabolkin MI; Nosikov VV
    Med Sci Monit; 2002 Mar; 8(3):CR180-4. PubMed ID: 11887032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of autoimmune thyroid disease.
    Weetman AP
    Horm Metab Res; 2009 Jun; 41(6):421-5. PubMed ID: 19343617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians.
    Thabet MM; Wesoly J; Slagboom PE; Toes RE; Huizinga TW
    Ann Rheum Dis; 2007 Jun; 66(6):803-6. PubMed ID: 17179172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
    Namo Cury A; Longui CA; Kochi C; Calliari LE; Scalissi N; Salles JE; Neves Rocha M; Barbosa de Melo M; Rezende Melo M; Monte O
    Horm Res; 2008; 70(1):36-41. PubMed ID: 18493148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease.
    Song HD; Liang J; Shi JY; Zhao SX; Liu Z; Zhao JJ; Peng YD; Gao GQ; Tao J; Pan CM; Shao L; Cheng F; Wang Y; Yuan GY; Xu C; Han B; Huang W; Chu X; Chen Y; Sheng Y; Li RY; Su Q; Gao L; Jia WP; Jin L; Chen MD; Chen SJ; Chen Z; Chen JL
    Hum Mol Genet; 2009 Mar; 18(6):1156-70. PubMed ID: 19126779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.
    Syed AA; Simmonds MJ; Brand OJ; Franklyn JA; Gough SC; Heward JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):663-7. PubMed ID: 17608818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
    Frydecka I; Daroszewski J; Suwalska K; Zołedziowska M; Tutak A; Słowik M; Potoczek S; Dobosz T
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):369-74. PubMed ID: 15507878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.